OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 18 citing articles:

The Beneficial and Adverse Effects of Autophagic Response to Caloric Restriction and Fasting
Roya Shabkhizan, Sanya Haiaty, Marziyeh Sadat Moslehian, et al.
Advances in Nutrition (2023) Vol. 14, Iss. 5, pp. 1211-1225
Open Access | Times Cited: 35

Management of metabolic-associated fatty liver disease: The diabetology perspective
Mohammad Sadiq Jeeyavudeen, Shahanas K A Khan, Sherouk Fouda, et al.
World Journal of Gastroenterology (2023) Vol. 29, Iss. 1, pp. 126-143
Open Access | Times Cited: 34

Small Intestinal Bacterial Overgrowth and Non-Alcoholic Fatty Liver Disease: What Do We Know in 2023?
Anna Gudan, Katarzyna Kozłowska‐Petriczko, Ewa Wunsch, et al.
Nutrients (2023) Vol. 15, Iss. 6, pp. 1323-1323
Open Access | Times Cited: 24

Cardiometabolic index: A new predictor for metabolic associated fatty liver disease in Chinese adults
Shaojie Duan, Deshuang Yang, Hui Xia, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 31

Evaluation and Management of Nutritional Consequences of Chronic Liver Diseases
Silvia Espina, Diego Casas Deza, Vanesa Bernal Monterde, et al.
Nutrients (2023) Vol. 15, Iss. 15, pp. 3487-3487
Open Access | Times Cited: 22

Effects of intermittent fasting regimens on glycemic, hepatic, anthropometric, and clinical markers in patients with non-alcoholic fatty liver disease: Systematic review and meta-analysis of randomized controlled trials
Saleh A. K. Saleh, Heitor O. Santos, Mihnea‐Alexandru Găman, et al.
Clinical Nutrition ESPEN (2023) Vol. 59, pp. 70-80
Closed Access | Times Cited: 12

Beneficial effects of intermittent fasting on nonalcoholic fatty liver disease: a narrative review
Qingxuan Deng, Ruyue Lv, Haoqi Zou, et al.
Egyptian Liver Journal (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 4

Special correlation between diet and MASLD: positive or negative?
Jia Liu, C. S. Li, Yun Yang, et al.
Cell & Bioscience (2025) Vol. 15, Iss. 1
Open Access

Metabolic-Associated Fatty Liver Disease and Diabetes
Nitin Kapoor, Sanjay Kalra
Endocrinology and Metabolism Clinics of North America (2023) Vol. 52, Iss. 3, pp. 469-484
Closed Access | Times Cited: 7

The role of intermittent fasting and the ketogenic diet in cancer disease: can they replace the Mediterranean diet?
Aleyna Nur Küçük, Seda Çiftçi
European Journal of Cancer Prevention (2023) Vol. 32, Iss. 6, pp. 533-543
Closed Access | Times Cited: 7

Effects of intermittent calorie restriction in non-diabetic patients with metabolic dysfunction-associated steatotic liver disease
Han Ah Lee, Hyeyoung Moon, Yuri Kim, et al.
Clinical Gastroenterology and Hepatology (2024) Vol. 23, Iss. 1, pp. 114-123.e13
Closed Access | Times Cited: 2

Fad diets for non-dialysis chronic kidney disease patients: Can “the miracle diet” be a threat?
Isabela de Souza da Costa Brum, L. Cardozo, Lívia Alvarenga, et al.
Nutrition (2024) Vol. 132, pp. 112668-112668
Closed Access

Dietary and nutrition considerations in caring for patients with nonalcoholic fatty liver disease: Updates for the practicing clinician
Carolyn Newberry, Sonal Kumar
Nutrition in Clinical Practice (2022) Vol. 38, Iss. 1, pp. 70-79
Closed Access | Times Cited: 1

Role of Nutrition in Preventing Liver Disease
Madeleine Haff, Arpan Mohanty
Current Hepatology Reports (2023) Vol. 22, Iss. 2, pp. 74-81
Closed Access

Page 1

Scroll to top